Article Text

Original research
Evaluation of compliance with early postbirth follow-up and unnecessary visits to the paediatric emergency department: a prospective observational study at the Lenval Children’s Hospital in Nice
  1. Antoine Tran1,2,3,
  2. Anne-Laure Hérissé1,
  3. Marion Isoardo1,
  4. Petri Valo1,4,
  5. Anne-Marie Maillotte5,
  6. Hervé Haas1,6,
  7. Dominique Donzeau7,
  8. Emma Freyssinet1,
  9. Christian Pradier2,8,
  10. Stéphanie Gentile3
  1. 1Paediatric Emergency Department, Hôpitaux Pédiatriques de Nice CHU-LENVAL, Nice, Provence-Alpes-Côte d'Azur, France
  2. 2Medical School, Université Côte d'Azur, Nice, France
  3. 3Equipe de Recherche EA 3279 - Centre d’Études et de Recherche sur les Services de Santé et la Qualité de Vie, Aix-Marseille Université, Marseille, France
  4. 4School of computing, University of Eastern Finland, Joensuu, Pohjois-Karjala, Finland
  5. 5Neonatology, Centre Hospitalier Universitaire de Nice, Nice, Provence-Alpes-Côte d'Azur, France
  6. 6Paediatric Department, Princess Grace Hospital Centre, Monaco
  7. 7Department of Clinical Research and Innovation, Centre Hospitalier Universitaire de Nice, Nice, Provence-Alpes-Côte d'Azur, France
  8. 8Department of Public Health, Centre Hospitalier Universitaire de Nice, Nice, Provence-Alpes-Côte d'Azur, France
  1. Correspondence to Dr Antoine Tran; tran.a{at}


Objective To evaluate compliance with the French National Authority for Health’s (Haute Autorité de Santé, HAS) postbirth follow-up recommendations for newborns attending our paediatric emergency department (PED) and identify risk factors associated with non-compliance and unnecessary emergency department utilisation.

Design Prospective, single centre.

Setting Fourth biggest PED in France in terms of attendance (CHU-Lenval).

Patients 280 patients of whom 249 were included in the statistical analysis.

Main outcome measures The primary outcome of this study was the evaluation of compliance of the care pathway for newborns consulting at the PED with respect to the French postbirth follow-up recommendations. Secondary outcome was the assessment of whether the visit to the PED was justified by means of PED reception software and two postconsultation interviews

Results 77.5% (193) of the newborns had non-compliant care pathways and 43% (107) of PED visits were unnecessary. Risk factors associated with a non-compliance regarding the HAS’s postbirth follow-up recommendations were: unnecessary visit to the PED (OR 2.0, 95% CI 1.1 to 3.9), precariousness (OR 2.8, 95% CI 1.4 to 6.2), birth in a public maternity hospital (OR 2.5, 95% CI 1.3 to 4.8) and no information about HAS’s postbirth follow-up recommendations on discharge from maternity ward (OR 11.4, 95% CI 5.8 to 23.3). Risk factors for unnecessary PED visits were: non-compliant care pathway (OR 2.0, 95% CI 1.1 to 3.9) and a first medical visit at a PED (OR 1.8, 95% CI 1.1 to 3.1).

Conclusion Postbirth follow-up may lead to decrease unnecessary emergency department visits unnecessary emergency department visits.

Trial registration number The study bears the clinical trial number NCT02863627.

  • paediatric A&E and ambulatory care
  • perinatology
  • primary care
  • organisation of health services

Data availability statement

Data are available on reasonable request.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Strengths and limitations of this study

  • This is the first study to analyse the care pathway for newborn visits to a paediatric emergency department.

  • This was a single-centre study with a relatively small sample size limiting applicability in general population.

  • The absence of a control group did not allow comparison of compliance and non-compliance with the French National Authority for Health’s postbirth follow-up recommendations.

  • Our analysis did not reach the target sample size.


Newborns attending an emergency department (ED) represent a public health concern. For example, overall in the USA, 7.7% of children are taken to an ED during their first month of life.1 An identical rate was found in a study conducted in Northern Ireland.2

In the Paediatric Hospitals of Nice University Hospital Centre (CHU-Lenval) (France), newborns represented 1.4% (811 newborns) of visits to the paediatric ED (PED) in 2016. This prevalence is constant (806 newborns or 1.4% of visits in 2015). However, most of the reasons for the visits are related to childcare and could be managed upstream by a general practitioner. The number of real newborn emergencies after discharge from the maternity ward are scarce.2 An unpublished pilot study, carried out in 2001 at Lenval Paediatric Emergencies (Nice, France), showed that almost 50% of the consultations were resolved by simple childcare advice.

Previous studies2–5 have shown that a diagnosis of a ‘healthy newborn’ is retained in 10%–34% of newborn visits to the PED, and that the visit is unnecessary in 45%–52% of cases.6–8 Therefore, a large part of the consultations would fall within the scope of work of a general practitioner. Meara et al9 showed that a follow-up programme after early discharge from the maternity ward reduced the rate of newborn attendance at a PED within 21 days by 10%.

In Europe, the postdischarge follow-up of newborns differs from country to country. In France, before 2014, data from the French national perinatal survey revealed significant differences in care both for postpartum women and their newborns, in terms of length of stay in the maternity ward and the offer of medical follow-up on discharge. This report highlights differences in follow-up mainly related to the characteristics of the place of delivery. Ideally, the length of stay should take into account the availability of out-of-hospital resources ensuring a suitable follow-up for both newborns and their mothers on discharge.10 11

Following an increase in early maternity ward discharges, the French National Authority for Health (Haute Autorité de Santé (HAS)) published a report in 2014 to suggest a care framework for newborns.12 The new recommendations include a medical visit to a paediatrician (or a general practitioner with an expertise in newborn follow-up) between 6 and 10 days of age. However, barriers to applying the framework include differences in care networks throughout France with follow-up being provided by various health professionals on discharge such as physicians (paediatricians or not), midwives, paediatric nurses or the Maternal and Child Healthcare Service. To facilitate application of the recommendations, the regional network of prenatal care of Nice (Mediterranean network) introduced an information sheet into the children’s health booklets (which is kept by the parents and updated at each medical consultation) in April 2016 (online supplemental appendix 1). This sheet includes a reminder that the first medical visit after discharge from the maternity ward should take place at age 6–10 days, and outlines symptoms which require urgent medical consultation.13 However, there are no studies concerning the impact of these new recommendations on the inappropriate use of PED during the first month of life.

The main objective of this study was to evaluate compliance with the HAS’s postbirth follow-up recommendations for newborns attending our PED. The secondary objectives were to evaluate whether the PED visit was justified and then to estimate the risk factors associated with a non-compliance according to the HAS recommendations and/or inappropriate use of the PED.



This was a prospective study conducted in the PED of the CHU-Lenval in Nice, France. This PED is the fourth largest in France in terms of attendance (59 010 admissions in 2016) and is the only University Hospital Department of Paediatric Emergencies in the Alpes-Maritimes and Var departments in the southeast of France.


The sample size was calculated based on a preliminary retrospective evaluation of the care pathway of 94 newborns who had attended the PED. With a 10% margin and absolute accuracy of 5%, the number of participants needed was 280. The participants were included by the attending paediatrician during their visit to the PED. The data were collected using the PED software ‘Terminal Urgences‘. To gather follow-up data, the parents were contacted twice after the PED visit. The inclusion period was 4 July 2016 to 6 January 2017. Inclusion criteria were the following: any newborn attending the PED of the University Hospital Centre (CHU)-Lenval Children’s Hospital, affiliated to the French healthcare system, and for whom both parents signed a non-objection form. The only non-inclusion criterion was parental refusal.

Primary and secondary endpoints

The primary endpoint was assessment of the compliance or non-compliance with the national guidelines of the care pathway for the follow-up of newborns consulting at the PED. The newborn’s care pathway was defined as compliant if the recommended HAS medical consultation had been carried out with a paediatrician (or a general practitioner) between 6 and 10 days of age.

The secondary endpoints included assessment of whether the visit to the PED was justified. According to previous studies, only 10%–37% of newborns are referred to a PED by a health professional.2 3 5 Additional examinations (blood tests, imaging, etc) are carried out for 32%–44%3 5 14 and newborns are hospitalised in 13%–47% of cases.2 3 5 14 These three last criteria can be used to define whether the PED visit is necessary or not. As a result, we used the following definitions: PED visit was justified if the newborn was referred by a health professional, and/or additional examinations were carried out during the PED visit, and/or the newborn was subsequently hospitalised. Additional examinations were defined as any use of resources that are not commonly available by healthcare providers outside the hospital: point-of-care testing (quick blood test), ECG, blood test, urinalysis, imaging, hospitalisation regardless of the duration and/or reason.

Risk factors associated with a non-compliance according to the HAS recommendations and/or an unnecessary visit to the PED were: the clinical and demographic characteristics of the newborn, the parents’ social characteristics (profession classified according to the Socio-Professional Classification of the National Institute of Statistics and Economic Studies; precariousness assessed by the Assessment score of Precariousness and Health Inequalities for the Centres of Health Examinations (EPICES) (defined as precarious if EPICES score >30),15 the use of resources during the PED visit, the newborn’s care pathway during the first month of life, the information provided to parents in the maternity ward concerning the date of the first medical consultation after discharge and the symptoms requiring an emergency medical consultation.


Two interviews were carried out after the PED visit. These interviews were performed by two trained clinical researchers of the Department of Clinical Research and Innovation of Nice University Hospital (MI and DD). The first interview took place 2–7 days after the visit to the PED to collect the data concerning the newborn, the parents and any medical or paramedical consultations carried out (questionnaire 1) (online supplemental appendix 2). The second interview took place within a week after the newborn’s first month of life. This interview focused on any other medical consultations since the first telephone interview to establish the child’s complete care pathway (questionnaire 2) (online supplemental appendix 3).

The patients were considered as ‘lost to follow-up’ if the parents could not be reached during the telephone interviews. The parents were called three times at different times of the day if they did not pick up, and this was repeated once in 48 hours (ie, a maximum of six attempts to call).

Statistical analysis

Continuous variables are expressed as a mean (SD) and median (first and third quartile). Categorical variables are expressed as percentages with a 95% CI. The χ2 test and Fisher’s exact test (when size <10) were used to compare the percentages. The Student’s t-test and Mann-Whitney U-test were used to compare the means after checking the normality of the distributions. The effect sizes were calculated using the contingency coefficient for significant χ2 test and the Cohen statistic d for a significant Student’s t-test: ‘weak’ (d=0.2–0.5), ‘moderate’ (d=0.5–0.8) and ‘strong’ (d>0.8).16

After describing the characteristics of the newborns according to the care pathway and then the PED consultation, we carried out two multivariate logistic regression analyses to estimate the risk factors associated with a non-compliant care pathway with the HAS recommendations (model 1) and an unnecessary visit to the PED (model 2). The modelling of categorical variables was studied using the likelihood ratio test. The selection of predictor variables was performed using a bottom-up, step-by-step procedure. Model 1 was adjusted for gender while model 2 was adjusted for gender and age at the time of the PED visit.

The fit of the regression model was assessed using the Hosmer-Lemeshow test (p=0.484 and p=0.695, respectively). ORs are expressed with a 95% CI.

The significance level p was fixed at 0.05. All statistical analyses were performed using STATA V.10.0 and R Studio V.3.2.2 for Macintosh.

Patient and public involvement

There was no patient or public involvement in the design of this protocol.


During the study period, 510 newborns attended our PED. Among these, 230 patients were not included in the study and a further 31 were excluded from analysis (figure 1). Therefore, 249 newborns were included in the final analysis. The gender distribution of the 249 newborns was well balanced (49.8% female). The population characteristics can be found in table 1.

Figure 1

Patient flow chart. a The reasons why eligible children were not included were probably related to workload and the organisation of medical and paramedical teams. PED, paediatric emergency department.

Table 1

Characteristics of the newborns

Overall, the care pathways for 193 newborns (77.5%) were non-compliant with the HAS’s postbirth follow-up recommendations (ie, no medical consultation between 6 and 10 days of age) and 55 (22.1%) did not receive any medical follow-up during their first month of life (table 2). One hundred and seventy-three newborns (69.5%) were followed by a midwife. Only 68 (27.3%) of the parents reported having received correct information on discharge from the maternity ward about consulting a paediatrician or general practitioner between 6 and 10 days of age.

Table 2

Description of the newborn care pathways

The PED visit was unnecessary in 43.0% (107 patients) of the cases (table 3). The main reason retained for the visit was ‘Excessive worry’ (20.5%).

Table 3

Details of consultations at the paediatric emergency department

In multivariate regression analysis (model 1, table 4), only an unnecessary visit and lack of information were significantly associated with a care pathway that is non-compliant with the follow-up recommendations with an adjusted OR of 2.6 (95% CI 1.2 to 5.5; p=0.016) and 10.0 (95% CI 4.8 to 20.7; p<0.001), respectively. Follow-up by a private paediatrician was significantly associated with a compliant care pathway with an adjusted OR of 0.2 (95% CI 0.1 to 0.5; p=0.001). A visit to the PED during on-call care hours, being a first-time parent, and lack of information (model 2, table 5) were significantly associated with an unnecessary visit with an adjusted OR of 1.8 (95% CI 1.0 to 3.3; p=0.039), 3.0 (95% CI 1.7 to 5.2; p=0.001) and 4.5 (95% CI 2.5 to 8.1; p=0.001), respectively.

Table 4

Risk factors associated with a non-compliant care pathway

Table 5

Risk factors associated with unnecessary visit to PED


This study was the first to analyse the care pathway for newborns admitted to a PED according to the French recommendations introduced in 2014. Only 22.5% of the newborns analysed in the study had a compliant care pathway which was a factor contributing to a justified visit to the PED. Conversely, newborns with a non-compliant care pathway were more likely to have an unnecessary visit to the PED. It would, therefore, seem that a medical consultation between 6 and 10 days of age avoids unnecessary and visits to PEDs. Gazmararian et al17 reported the general practitioner or the paediatrician are the most reliable sources of information for mothers. If the paediatrician is seen later after discharge from the maternity ward, EDs tend to be a substitute for this source of information: according to our results the first medical contact after leaving the maternity ward was the paediatrician of the PED for 145 newborns (58.2%).

Our study suggests that the main barrier for compliance with the national follow-up recommendations for newborns, lies in the quality of the information about the care pathway provided to the parents in the maternity ward: 46.2% of the parents felt they had not received enough information. An information sheet reminding the parents to consult for a first medical visit (online supplemental appendix 1) was given to all parents on discharge from the maternity ward. However, a study by Schimmel et al18 suggests that parental adherence to postnatal recommendations is better if explained orally and not just in writing.

Although a follow-up by a paediatric practitioner emerged as a significant factor in the compliant care pathway, in France the parents can also consult at a maternal and child healthcare centre, especially in specific situations such as preterm birth, low birth weight, twin birth or social difficulties when detected during the pregnancy or the maternity ward stay. However, getting an appointment in time, whether with a paediatric nurse or a doctor, is often not possible which means that the recommended time window for the first medical visit (age 6–10 days) cannot be respected.

In our study, 69.5% of the newborns had a first consultation with a midwife at 6 days of age on average. However, this does not meet the care pathway criterion defined by the HAS recommendations which stipulate that a paediatrician or general practitioner with expertise in paediatrics must be seen. We cannot, therefore, draw a conclusion about this point.

Moreover, only precariousness emerged as a risk factor for a non-compliant care pathway. This is similar to an adult population for whom it is known that precariousness constitutes a risk of disruption in the care pathway.19–21

While few studies have described the care pathway for newborns, many authors have focused on newborns attending a PED. In our study, the PED visit was unnecessary in 43% of the cases that is close to the prevalence found in the literature (45.3%–52.4%).6–8

‘Excessive worry’ was retained as the main reason for 20.5% of consultations. In addition, about half (44.6%) of the consultations ended with simple childcare advice without any medical prescription. This supports the notion that parental education can help prevent unnecessary visits to the ED.22–24

Our results are aligned with those from a study by Flanagan and Stewart2 regarding visits during on-call care hours in that consultation during working days is associated with an increased risk of hospitalisation. Claudet et al14 also reported that a low-severity reason for consultation was a risk factor for consulting at night. Unlike other studies we did not find that risk factors (such as a mother aged under 25 years and a newborn under 15 days), or protective factors (such as preterm birth),6–8 were significant.

Several limitations to our study deserve to be mentioned. To eliminate the bias influenced by our local healthcare network and consequently render our results more generalisable to other settings in France, it would have been interesting to compare our data with several French cities. In addition, a study carried out on all newborns, rather than those consulting at a PED, would provide a more comprehensive view of the care process. Furthermore, the absence of a control group in our study does not allow us to compare the care pathway set up by paediatricians (or general practitioners with an expertise in newborn follow-up). During our study period, the newborns attending the PED only represented 12% of all births registered in Nice and its surroundings.

However, standardised questionnaires completed by trained interviewers enabled optimal and comprehensive data collection. The response rate was acceptable (88.9%) and the data was not interpreted until all the questionnaires were completed, thus avoiding bias.

In our study, while we used intervention as proof that the visit to the PED was justified, this alone is not sufficient to distinguish between a justified and non-justified visit as physicians may undertake unnecessary workups to alleviate parental anxiety, for example.

Finally, 149 children (29.2%) potentially meeting the inclusion criteria were not included probably due to the workload and the organisation of medical and paramedical teams. However, according to our records, their profiles did not differ from those who were included in terms of gender, age, resource utilisation.


The newborn care pathway recommended by the HAS in 2014 seems to be difficult to apply. However, postbirth follow-up may lead to decrease unnecessary ED visits. A medical consultation with a paediatrician between 6 and 10 days is an essential element in the care pathway. Several areas for improvement could be proposed: the monitoring of the newborn should be anticipated and discussed with the parents before giving birth (prenatal consultations, childbirth preparation meetings), a hospital consultation could be offered for particular situations (social difficulties) and finally the follow-up consultation between 6 and 10 days of age, if not performed by a doctor, could be provided by a midwife.

Data availability statement

Data are available on reasonable request.

Ethics statements

Patient consent for publication

Ethics approval

This study and was approved by Clinical Research Ethics Committee of the University Hospital Centre of Nice No 16-HPNCL-04.


Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.


  • Contributors AT was responsible for protocol development, analyses, writing of the paper and the main author of the paper. A-LH was responsible for protocol development and supervised the analyses, writing of the paper. MI supervised the protocol development, data collection, writing of the paper, conducted the interviews. PV assisted in analyses, supervised the writing of the paper and had a main contribution to the editing of the paper. A-MM was responsible for protocol development and supervised the writing of the paper. HH supervised the protocol development, writing of the paper. DD was responsible for the data collection, supervised the protocol development and conducted the interviews. EF supervised the writing of the paper. CP supervised the protocol development, analyses and writing of the paper. SG supervised the protocol development, analyses and writing of the paper.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.